Fresenius Medical Care AG
FMS23.060USD
+0.315+1.38%
Close 01/09, 16:00（ET）Quotes delayed by 15 min
6.68BMarket Cap
16.96P/E TTM
More Details of Fresenius Medical Care AG Company
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Fresenius Medical Care AG Info
Ticker SymbolFMS
Company nameFresenius Medical Care AG
IPO dateOct 02, 1996
CEOCordola (Craig)
Number of employees111513
Security typeDepository Receipt
Fiscal year-endOct 02
AddressElse-Kroener-Strasse 1
CityBAD HOMBURG VOR DER HOHE
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryGermany
Postal code61352
Phone4961726090
Websitehttps://www.freseniusmedicalcare.com/
Ticker SymbolFMS
IPO dateOct 02, 1996
CEOCordola (Craig)
Company Executives of Fresenius Medical Care AG
Name
Name/Position
Position
Shareholding
Change
Ms. Pascale Witz
Ms. Pascale Witz
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
--
--
Ms. Helen Giza
Ms. Helen Giza
Chairman of the Management Board, Chief Executive Officer
Chairman of the Management Board, Chief Executive Officer
--
--
Mr. A. Gregory Sorensen, M.D.
Mr. A. Gregory Sorensen, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Martin Fischer
Mr. Martin Fischer
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Mr. Craig Cordola, Ed.D.
Mr. Craig Cordola, Ed.D.
Member of the Management Board, Chief Executive Officer - Care Delivery
Member of the Management Board, Chief Executive Officer - Care Delivery
--
--
Mr. Michael Sen
Mr. Michael Sen
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
--
Mr. Shervin J. Korangy
Mr. Shervin J. Korangy
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Pascale Witz
Ms. Pascale Witz
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
--
--
Ms. Helen Giza
Ms. Helen Giza
Chairman of the Management Board, Chief Executive Officer
Chairman of the Management Board, Chief Executive Officer
--
--
Mr. A. Gregory Sorensen, M.D.
Mr. A. Gregory Sorensen, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
North America
14.78B
70.68%
Rest of the world
5.61B
26.84%
Germany
518.03M
2.48%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Pzena Investment Management, LLC
2.56%
Wellington Management Company, LLP
1.42%
Fiduciary Management, Inc.
0.94%
Dodge & Cox
0.66%
Todd Asset Management LLC
0.22%
Other
94.20%
Shareholders
Shareholders
Proportion
Pzena Investment Management, LLC
2.56%
Wellington Management Company, LLP
1.42%
Fiduciary Management, Inc.
0.94%
Dodge & Cox
0.66%
Todd Asset Management LLC
0.22%
Other
94.20%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
5.15%
Investment Advisor
2.13%
Hedge Fund
0.35%
Research Firm
0.25%
Pension Fund
0.14%
Family Office
0.02%
Bank and Trust
0.01%
Other
91.95%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
346
46.58M
8.04%
-2.99M
2025Q3
337
47.00M
8.12%
-7.47K
2025Q2
350
47.02M
8.22%
+2.00M
2025Q1
348
45.04M
8.08%
-2.40M
2024Q4
337
43.94M
8.01%
+456.34K
2024Q3
325
43.49M
7.70%
+2.26M
2024Q2
343
41.23M
8.48%
-1.66M
2024Q1
362
42.90M
8.31%
-5.86M
2023Q4
362
42.80M
8.39%
+76.36K
2023Q3
367
42.72M
8.58%
-1.02M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Pzena Investment Management, LLC
14.82M
2.56%
+153.87K
+1.05%
Sep 30, 2025
Wellington Management Company, LLP
8.20M
1.42%
--
--
Sep 30, 2025
Fiduciary Management, Inc.
5.46M
0.94%
-198.98K
-3.52%
Sep 30, 2025
Dodge & Cox
3.83M
0.66%
--
--
Sep 30, 2025
Todd Asset Management LLC
1.30M
0.22%
+64.31K
+5.19%
Sep 30, 2025
Aristotle Capital Management, LLC
1.13M
0.2%
-7.00K
-0.61%
Sep 30, 2025
Parametric Portfolio Associates LLC
985.01K
0.17%
+12.65K
+1.30%
Sep 30, 2025
Morgan Stanley & Co. International Plc
908.00K
0.16%
-350.00K
-27.82%
Sep 30, 2025
Janus Henderson Investors
829.14K
0.14%
+300.92K
+56.97%
Jun 30, 2025
Kentucky Teachers' Retirement System
816.20K
0.14%
+62.70K
+8.32%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Cultivar ETF
1.01%
ActivePassive International Equity ETF
0.08%
Avantis Responsible International Equity ETF
0.06%
Avantis International Equity ETF
0.01%
Pacer Developed Markets International Cash Cws 100
0%
Unusual Whales Subversive Democratic Trading ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
SGI Enhanced Global Income ETF
0%
Unusual Whales Subversive Republican Trading ETF
0%
The Opal International Dividend Income ETF
0%
View more
Cultivar ETF
Proportion1.01%
ActivePassive International Equity ETF
Proportion0.08%
Avantis Responsible International Equity ETF
Proportion0.06%
Avantis International Equity ETF
Proportion0.01%
Pacer Developed Markets International Cash Cws 100
Proportion0%
Unusual Whales Subversive Democratic Trading ETF
Proportion0%
DFA Dimensional International Core Equity 2 ETF
Proportion0%
SGI Enhanced Global Income ETF
Proportion0%
Unusual Whales Subversive Republican Trading ETF
Proportion0%
The Opal International Dividend Income ETF
Proportion0%
Dividend
A total of
1.59B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
May 07, 2025
FMS.NB Final Cash Dividend of gross USD 0.814968 paid on Jun 06, 2025 going ex on May 23, 2025
May 23, 2025
Jun 06, 2025
May 23, 2025
Apr 15, 2024
FMS.NB Final Cash Dividend of gross USD 0.642838 paid on Jun 03, 2024 going ex on May 17, 2024
May 20, 2024
Jun 03, 2024
May 17, 2024
May 03, 2023
FMS.NB Final Cash Dividend of gross USD 0.604856 paid on Jun 01, 2023 going ex on May 17, 2023
May 18, 2023
Jun 01, 2023
May 17, 2023
Apr 28, 2022
FMS.NB Final Cash Dividend of gross USD 0.708547 paid on May 27, 2022 going ex on May 13, 2022
May 16, 2022
May 27, 2022
May 13, 2022
May 16, 2021
FMS.NB Final Cash Dividend of gross USD 0.819276 paid on Jun 07, 2021 going ex on May 24, 2021
May 25, 2021
Jun 07, 2021
May 24, 2021
Aug 12, 2020
FMS.NB Final Cash Dividend of gross USD 0.71688 paid on Sep 11, 2020 going ex on Aug 28, 2020
Aug 31, 2020
Sep 11, 2020
Aug 28, 2020
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Fresenius Medical Care AG?
The top five shareholders of Fresenius Medical Care AG are:
Pzena Investment Management, LLC holds 14.82M shares, accounting for 2.56% of the total shares.
Wellington Management Company, LLP holds 8.20M shares, accounting for 1.42% of the total shares.
Fiduciary Management, Inc. holds 5.46M shares, accounting for 0.94% of the total shares.
Dodge & Cox holds 3.83M shares, accounting for 0.66% of the total shares.
Todd Asset Management LLC holds 1.30M shares, accounting for 0.22% of the total shares.
Pzena Investment Management, LLC holds 14.82M shares, accounting for 2.56% of the total shares.
Wellington Management Company, LLP holds 8.20M shares, accounting for 1.42% of the total shares.
Fiduciary Management, Inc. holds 5.46M shares, accounting for 0.94% of the total shares.
Dodge & Cox holds 3.83M shares, accounting for 0.66% of the total shares.
Todd Asset Management LLC holds 1.30M shares, accounting for 0.22% of the total shares.
What are the top three shareholder types of Fresenius Medical Care AG?
The top three shareholder types of Fresenius Medical Care AG are:
Pzena Investment Management, LLC
Wellington Management Company, LLP
Fiduciary Management, Inc.
Pzena Investment Management, LLC
Wellington Management Company, LLP
Fiduciary Management, Inc.
How many institutions hold shares of Fresenius Medical Care AG (FMS)?
As of 2025Q4, 346 institutions hold shares of Fresenius Medical Care AG, with a combined market value of approximately 46.58M, accounting for 8.04% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.08%.
What is the biggest source of revenue for Fresenius Medical Care AG?
In FY2024, the -- business generated the highest revenue for Fresenius Medical Care AG, amounting to -- and accounting for --% of total revenue.
